Europe’s Cryochambers Market will reach US$ 65.4 Mn by 2026-end

Proactive lifestyle and fluctuating temperatures experienced across the European region are, at many times, the cause of several chronic disorders. Growing incidence of chronic medical conditions, coupled with distress caused due to unfavorable temperature changes, continue to stimulate the adoption of cryotherapy in Europe. Persistence Market Research’s recent report on Europe’s cryochambers market delivers insights on how the temperature-based medical therapy is picking up momentum. Decreasing inflammation, increasing metabolism and reduction of chronic pain & fatigue are some of the essential benefits of cryotherapy that will continue to compel the use of cryochambers in Europe. The report estimates that a little over US$ 65 Mn worth of cryochambers are expected to be sold in Europe by the end of 2026.

In 2016, the Europe crychambers market was valued at US$ 43 Mn, and is anticipated to register a steady growth at 5.4% CAGR during the forecast period. Demand for cryochambers is also expected to rise in Europe, owing to improving outcomes of cryotherapy and prevalence of health trends. In order to boost personal happiness and increase performance levels, urban consumers in European countries will be opting for cryotherapy as a remedy to their hectic livelihood.

In the report, titled “Cryochambers Market: Europe Industry Analysis and Forecast, 2016-2026,” Germany, France, Poland and the UK are projected to be at the forefront of Europe’s cryochambers market. These countries will continue to dominate the market with a revenue share of more than 10%. The report further reveals that throughout the forecast period, the consumption of multiple-person cryochamber will be considerable higher than individual cryochambers. Over two-third of Europe’s cryochamber revenues will be accounted by sales of multiple-person units across the region.

Request to Sample Report @ https://www.persistencemarketresearch.com/samples/14374

The report estimates that in 2016, more than 200 units of cryochambers were sold across Europe, anticipating that this number could rise at 6.3% CAGR and reach 336 by the end of 2026. Almost every boon attained from undertaking cryotherapy helps in rejuvenating ones’ personal appearance, which is why the report expects higher consumption of cryochambers by dermatologists for cosmetic applications. Through 2026, every other cryochamber sold in Europe is likely to be used for dermatology or cosmetic applications. The need for cryochambers will also gain traction for sports medicine & pain management applications.

Request Report TOC @ https://www.persistencemarketresearch.com/methodology/14374

In Europe, the largest end-user of cryochambers is a fitness center or a beauty spa. Together, fitness centers and beauty spas spanned across European countries are presently accounting for more than 35% of market value. In the years to come, the demand for cryochambers will also grow vigorously in European sports clubs and athletic associations. The report has profiled leading companies partaking in the growth of Europe’s cryochambers market, which include Zimmer MedizinSysteme GmbH, KrioSystem Sp. z.o.o., Air Products and Chemicals, Inc., METRUM CRYOFLEX Sp. z o.o., Sp. K., Novotech S.R.O, CryoAction Limited, Juka Sp. Z.O.O Sp.K., Cryosense, and CRYO Science.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353

This release was published on openPR.